NICE should not intervene where there is equipoise by virtue of insufficient evidence

Heart

Volumn 96, Issue 16, 2010, Pages 1333-

  Mohindra, R K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL ENDOCARDITIS; CARDIOLOGIST; HUMAN; LETTER; MEDICAL PRACTICE; NATIONAL INSTITUTE OF CLINICAL EXCELLENCE GUIDANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ANTIBIOTIC PROPHYLAXIS; ENDOCARDITIS, BACTERIAL; EVIDENCE-BASED MEDICINE; HUMANS; PRACTICE GUIDELINES AS TOPIC; THERAPEUTIC EQUIPOISE;

EID: 77955435767     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.200758     Document Type: Letter

References (4)

1. Shaw D, Conway DI. Pascal's Wager, infective endocarditis and the no-lose philosophy in medicine. Heart 2010;96:15-18.
2. Mohindra RK. NICE, drug-eluting stents and the limits of trial data. Heart 2009;95:505-6.
3. National Institute For Health And Clinical Excellence. Social value judgements. Principles for the development of NICE guidance. 2nd edn. Para 4.1 http://www.nice.org.uk/aboutnice/howwework/socialvaluejudgements/ socialvaluejudgements.jsp (accessed 13 Feb 2010).
4. Reg 2 Medicines for Human Use (Clinical Trials) Regulations, 2004 SI 2004/103. http://www.opsi.gov.uk/si/si2004/20041031.htm#2 (accessed 1 Jul 2010).